Apollo taps W2O as LAP-BAND AOR

Share this article:

Apollo EndoSurgery has tapped W2O Group as its agency of record for its LAP-BAND weight reduction system. The agency will look to lift the procedure's profile through advertising, digital engagement and multi-channel marketing efforts. "W2O came to the table with a deep understanding of what we are looking to achieve as a brand and how it fits into our portfolio of gastroenterological products,” president and CEO of Apollo Endosurgery Dennis McWilliams stated in a release.

Jim Weiss, CEO of W2O, offered, “We could not be more enthusiastic to partner with Apollo to write the next exciting chapter of the brand story.”

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.